Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metformin influences drug sensitivity in pancreatic cancer cells
Saverio Candido, Stephen L. Abrams, Linda S. Steelman, et al.
Advances in Biological Regulation (2018) Vol. 68, pp. 13-30
Closed Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

The effects of metformin on autophagy
Guangli Lu, Zhen Wu, Jia Shang, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 137, pp. 111286-111286
Open Access | Times Cited: 120
Molecular Mechanisms of Metformin for Diabetes and Cancer Treatment
Min Li, M Kellis, Huijie Zhang, et al.
Frontiers in Physiology (2018) Vol. 9
Open Access | Times Cited: 99
Targeting the Metabolic Paradigms in Cancer and Diabetes
Mira Bosso, Dania Haddad, Ashraf Al Madhoun, et al.
Biomedicines (2024) Vol. 12, Iss. 1, pp. 211-211
Open Access | Times Cited: 12
Metformin as a Radiation Modifier; Implications to Normal Tissue Protection and Tumor Sensitization
Keywan Mortezaee, Dheyauldeen Shabeeb, Ahmed Eleojo Musa, et al.
Current Clinical Pharmacology (2019) Vol. 14, Iss. 1, pp. 41-53
Closed Access | Times Cited: 73
Mitochondrial Metabolism in PDAC: From Better Knowledge to New Targeting Strategies
Gabriela Reyes‐Castellanos, Rawand Masoud, Alice Carrier
Biomedicines (2020) Vol. 8, Iss. 8, pp. 270-270
Open Access | Times Cited: 61
A review of lifestyle and environment risk factors for pancreatic cancer
Sara Zanini, Serena Renzi, Antonina Rita Limongi, et al.
European Journal of Cancer (2021) Vol. 145, pp. 53-70
Open Access | Times Cited: 44
Effects of TP53 Mutations and miRs on Immune Responses in the Tumor Microenvironment Important in Pancreatic Cancer Progression
James A. McCubrey, Li V. Yang, Stephen L. Abrams, et al.
Cells (2022) Vol. 11, Iss. 14, pp. 2155-2155
Open Access | Times Cited: 30
Synergistic anticancer effects of doxorubicin and metformin combination therapy: A systematic review
Fereshtehsadat Jalali, Fatemeh Fakhari, Afrah Sepehr, et al.
Translational Oncology (2024) Vol. 45, pp. 101946-101946
Open Access | Times Cited: 6
Signaling Networks That Control Cellular Plasticity in Pancreatic Tumorigenesis, Progression, and Metastasis
Howard C. Crawford, Marina Pasca di Magliano, Sulagna Banerjee
Gastroenterology (2019) Vol. 156, Iss. 7, pp. 2073-2084
Open Access | Times Cited: 53
The Role of Mitochondria in the Chemoresistance of Pancreatic Cancer Cells
Yibo Fu, Francesca Ricciardiello, Gang Yang, et al.
Cells (2021) Vol. 10, Iss. 3, pp. 497-497
Open Access | Times Cited: 40
Cellular metabolism in pancreatic cancer as a tool for prognosis and treatment (Review)
Michal Zuzčák, Ján Trnka
International Journal of Oncology (2022) Vol. 61, Iss. 2
Open Access | Times Cited: 25
Abilities of berberine and chemically modified berberines to inhibit proliferation of pancreatic cancer cells
Stephen L. Abrams, Matilde Y. Follo, Linda S. Steelman, et al.
Advances in Biological Regulation (2018) Vol. 71, pp. 172-182
Closed Access | Times Cited: 42
Obesity and pancreatic cancer: An update of epidemiological evidence and molecular mechanisms
Bin Zhou, Dong Wu, Han Liu, et al.
Pancreatology (2019) Vol. 19, Iss. 7, pp. 941-950
Closed Access | Times Cited: 40
Role of the malonyl-CoA synthetase ACSF3 in mitochondrial metabolism
Caitlyn E. Bowman, Michael J. Wolfgang
Advances in Biological Regulation (2018) Vol. 71, pp. 34-40
Open Access | Times Cited: 39
Introduction of WT-TP53 into pancreatic cancer cells alters sensitivity to chemotherapeutic drugs, targeted therapeutics and nutraceuticals
Stephen L. Abrams, Kvin Lertpiriyapong, Li V. Yang, et al.
Advances in Biological Regulation (2018) Vol. 69, pp. 16-34
Closed Access | Times Cited: 35
Abilities of berberine and chemically modified berberines to interact with metformin and inhibit proliferation of pancreatic cancer cells
Shaw M. Akula, Saverio Candido, Massimo Libra, et al.
Advances in Biological Regulation (2019) Vol. 73, pp. 100633-100633
Open Access | Times Cited: 35
ABCC3 is a novel target for the treatment of pancreatic cancer
Aleksandra Adamska, Riccardo Ferro, Rossano Lattanzio, et al.
Advances in Biological Regulation (2019) Vol. 73, pp. 100634-100634
Closed Access | Times Cited: 28
Cellular signaling and epigenetic regulation of gene expression in leukemia
Chandrika Gowda, Chunhua Song, Yali Ding, et al.
Advances in Biological Regulation (2019) Vol. 75, pp. 100665-100665
Open Access | Times Cited: 27
New tricks of old drugs: Repurposing non-chemo drugs and dietary phytochemicals as adjuvants in anti-tumor therapies
Mei Zhang, Xianfeng Chen, Norbert Radacsi
Journal of Controlled Release (2020) Vol. 329, pp. 96-120
Open Access | Times Cited: 27
TRIP13 promotes lung cancer cell growth and metastasis through AKT/mTORC1/c-Myc signaling
Weiyang Cai, Wei Ni, Yin Jin, et al.
Cancer Biomarkers (2020) Vol. 30, Iss. 2, pp. 237-248
Closed Access | Times Cited: 26
GSK-3β Can Regulate the Sensitivity of MIA-PaCa-2 Pancreatic and MCF-7 Breast Cancer Cells to Chemotherapeutic Drugs, Targeted Therapeutics and Nutraceuticals
Stephen L. Abrams, Shaw M. Akula, Akshaya K. Meher, et al.
Cells (2021) Vol. 10, Iss. 4, pp. 816-816
Open Access | Times Cited: 22
Pancreatic cancer tumorspheres are cancer stem-like cells with increased chemoresistance and reduced metabolic potential
Alice Domenichini, Jeanne S. Edmands, Aleksandra Adamska, et al.
Advances in Biological Regulation (2019) Vol. 72, pp. 63-77
Closed Access | Times Cited: 23
Drug Repurposing Opportunities in Pancreatic Ductal Adenocarcinoma
Rita Rebelo, Bárbara Polónia, Lúcio Lara Santos, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 3, pp. 280-280
Open Access | Times Cited: 18
Mitochondrial Metabolism in Pancreatic Ductal Adenocarcinoma: From Mechanism-Based Perspectives to Therapy
Hafiza Padinharayil, Vikrant Rai, Alex George
Cancers (2023) Vol. 15, Iss. 4, pp. 1070-1070
Open Access | Times Cited: 7
Roles of p53, NF-κB and the androgen receptor in controlling NGAL expression in prostate cancer cell lines
William H. Chappell, Saverio Candido, Stephen L. Abrams, et al.
Advances in Biological Regulation (2018) Vol. 69, pp. 43-62
Closed Access | Times Cited: 21
Page 1 - Next Page

Scroll to top